Tetratricopeptide repeat motifs in the world of bacterial pathogens: Role in virulence mechanisms

Infection and Immunity

Volumn 81, Issue 3, 2013, Pages 629-635

  Cerveny, Lukas ^a   Straskova, Adela ^b   Dankova, Vera ^a   Hartlova, Anetta ^c   Ceckova, Martina ^a   Staud, Frantisek ^a   Stulik, Jiri ^d  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c UMEÅ UNIVERSITY   (Sweden)

^d UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; TETRATRICOPEPTIDE REPEAT PROTEIN;

ARTICLE; BACTERIAL VIRULENCE; FRANCISELLA TULARENSIS; GENE SEQUENCE; LIGAND BINDING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PSEUDOMONAS AERUGINOSA; SHIGELLA; TETRATRICOPEPTIDE REPEAT; TYPE III SECRETION SYSTEM; YERSINIA;

AMINO ACID MOTIFS; BACTERIA; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; VIRULENCE;

EID: 84874736530     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01035-12     Document Type: Article

References (75)

1. Hirano T, Kinoshita N, Morikawa K, Yanagida M. 1990. Snap helix with knob and hole: essential repeats in S. pombe nuclear protein nuc2+. Cell 60:319-328.
2. Sikorski RS, Boguski MS, Goebl M, Hieter P. 1990. A repeating amino acid motif in CDC23 defines a family of proteins and a new relationship among genes required for mitosis and RNA synthesis. Cell 60:307-317.
3. Lamb JR, Tugendreich S, Hieter P. 1995. Tetratrico peptide repeat interactions: to TPR or not to TPR. Trends Biochem. Sci. 20:257-259.
4. D'Andrea LD, Regan L. 2003. TPR proteins: the versatile helix. Trends Biochem. Sci. 28:655-662.
5. Das AK, Cohen PW, Barford D. 1998. The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR-mediated protein-protein interactions. EMBO J. 17:1192-1199.
6. Büttner CR, Sorg I, Cornelis GR, Heinz DW, Niemann HH. 2008. Structure of the Yersinia enterocolitica type III secretion translocator chaperone SycD. J. Mol. Biol. 375:997-1012.
7. Job V, Mattei PJ, Lemaire D, Attree I, Dessen A. 2010. Structural basis of chaperone recognition of type III secretion system minor translocator proteins. J. Biol. Chem. 285:23224-23232.
8. Kim K, Oh J, Han D, Kim EE, Lee B, Kim Y. 2006. Crystal structure of PilF: functional implication in the type 4 pilus biogenesis in Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 340:1028-1038.
9. Lunelli M, Lokareddy RK, Zychlinsky A, Kolbe M. 2009. IpaB-IpgC interaction defines binding motif for type III secretion translocator. Proc. Natl. Acad. Sci. U. S. A. 106:9661-9666.
10. Grove TZ, Cortajarena AL, Regan L. 2008. Ligand binding by repeat proteins: natural and designed. Curr. Opin. Struct. Biol. 18:507-515.
11. Blatch GL, Lassle M. 1999. The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. Bioessays 21:932-939.
12. Goodarzi MO, Xu N, Cui J, Guo X, Chen YI, Azziz R. 2008. Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome. Hum. Reprod. 23:1214-1219.
13. Sohocki MM, Bowne SJ, Sullivan LS, Blackshaw S, Cepko CL, Payne AM, Bhattacharya SS, Khaliq S, Qasim Mehdi S, Birch DG, Harrison WR, Elder FF, Heckenlively JR, Daiger SP. 2000. Mutations in a new photoreceptor-pineal gene on 17p cause Leber congenital amaurosis. Nat. Genet. 24:79-83.
14. Grizot S, Fieschi F, Dagher MC, Pebay-Peyroula E. 2001. The active N-terminal region of p67phox. Structure at 1.8Aresolution and biochemical characterizations of the A128V mutant implicated in chronic granulomatous disease. J. Biol. Chem. 276:21627-21631.
15. Tsukahara F, Urakawa I, Hattori M, Hirai M, Ohba K, Yoshioka T, Sakaki Y, Muraki T. 1998. Molecular characterization of the mouse mtprd gene, a homologue of human TPRD: unique gene expression suggesting its critical role in the pathophysiology of Down syndrome. J. Biochem. 123: 1055-1063.
16. Cliff MJ, Harris R, Barford D, Ladbury JE, Williams MA. 2006. Conformational diversity in the TPR domain-mediated interaction of protein phosphatase 5 with Hsp90. Structure 14:415-426.
17. Scheufler C, Brinker A, Bourenkov G, Pegoraro S, Moroder L, Bartunik H, Hartl FU, Moarefi I. 2000. Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine. Cell 101:199-210.
18. Zhang Y, Chan DC. 2007. Structural basis for recruitment of mitochondrial fission complexes by Fis1. Proc. Natl. Acad. Sci. U. S. A. 104:18526-18530.
19. Cortajarena AL, Regan L. 2006. Ligand binding by TPR domains. Protein Sci. 15:1193-1198.
20. Cortajarena AL, Kajander T, Pan W, Cocco MJ, Regan L. 2004. Protein design to understand peptide ligand recognition by tetratricopeptide repeat proteins. Protein Eng. Des. Sel. 17:399-409.
21. Brinker A, Scheufler C, Von Der Mulbe F, Fleckenstein B, Herrmann C, Jung G, Moarefi I, Hartl FU. 2002. Ligand discrimination by TPR domains. Relevance and selectivity of EEVD-recognition in Hsp70 × Hop × Hsp90 complexes. J. Biol. Chem. 277:19265-19275.
22. Eckert K, Saliou JM, Monlezun L, Vigouroux A, Atmane N, Caillat C, Quevillon-Cheruel S, Madiona K, Nicaise M, Lazereg S, Van Dorsselaer A, Sanglier-Cianferani S, Meyer P, Morera S. 2010. The Pih1-Tah1 cochaperone complex inhibits Hsp90 molecular chaperone ATPase activity. J. Biol. Chem. 285:31304-31312.
23. Krachler AM, Sharma A, Kleanthous C. 2010. Self-association of TPR domains: lessons learned from a designed, consensus-based TPR oligomer. Proteins 78:2131-2143.
24. Lee JR, Lee SS, Jang HH, Lee YM, Park JH, Park SC, Moon JC, Park SK, Kim SY, Lee SY, Chae HB, Jung YJ, Kim WY, Shin MR, Cheong GW, Kim MG, Kang KR, Lee KO, Yun DJ, Lee SY. 2009. Heat-shock dependent oligomeric status alters the function of a plant-specific thioredoxinlike protein, AtTDX. Proc. Natl. Acad. Sci. U. S. A. 106:5978-5983.
25. Zeytuni N, Ozyamak E, Ben-Harush K, Davidov G, Levin M, Gat Y, Moyal T, Brik A, Komeili A, Zarivach R. 2011. Self-recognition mechanism of MamA, a magnetosome-associated TPR-containing protein, promotes complex assembly. Proc. Natl. Acad. Sci. U. S. A. 108:E480-E487.
26. Jínek M, Rehwinkel J, Lazarus BD, Izaurralde E, Hanover JA, Conti E. 2004. The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin alpha. Nat. Struct. Mol. Biol. 11:1001-1007.
27. Wu Y, Sha B. 2006. Crystal structure of yeast mitochondrial outer membrane translocon member Tom70p. Nat. Struct. Mol. Biol. 13:589-593.
28. Main ER, Jackson SE, Regan L. 2003. The folding and design of repeat proteins: reaching a consensus. Curr. Opin. Struct. Biol. 13:482-489.
29. Main ER, Xiong Y, Cocco MJ, D'Andrea L, Regan L. 2003. Design of stable alpha-helical arrays from an idealized TPR motif. Structure 11:497-508.
30. Sonnhammer EL, Eddy SR, Durbin R. 1997. Pfam: a comprehensive database of protein domain families based on seed alignments. Proteins 28:405-420.
31. Schultz J, Milpetz F, Bork P, Ponting CP. 1998. SMART, a simple modular architecture research tool: identification of signaling domains. Proc. Natl. Acad. Sci. U. S. A. 95:5857-5864.
32. Karpenahalli MR, Lupas AN, Soding J. 2007. TPRpred: a tool for prediction of TPR-, PPR-and SEL1-like repeats from protein sequences. BMC Bioinformatics 8:2. doi:10.1186/1471-2105-8-2.
33. Bröms JE, Edqvist PJ, Forsberg A, Francis MS. 2006. Tetratricopeptide repeats are essential for PcrH chaperone function in Pseudomonas aeruginosa type III secretion. FEMS Microbiol. Lett. 256:57-66.
34. Edqvist PJ, Bröms JE, Betts HJ, Forsberg A, Pallen MJ, Francis MS. 2006. Tetratricopeptide repeats in the type III secretion chaperone, LcrH: their role in substrate binding and secretion. Mol. Microbiol. 59:31-44.
35. Chakraborty S, Monfett M, Maier TM, Benach JL, Frank DW, Thanassi DG. 2008. Type IV pili in Francisella tularensis: roles of pilF and pilT in fiber assembly, host cell adherence, and virulence. Infect. Immun. 76: 2852-2861.
36. Chao J, Wong D, Zheng X, Poirier V, Bach H, Hmama Z, Av-Gay Y. 2010. Protein kinase and phosphatase signaling in Mycobacterium tuberculosis physiology and pathogenesis. Biochim. Biophys. Acta 1804:620-627.
37. Pallen MJ, Francis MS, Futterer K. 2003. Tetratricopeptide-like repeats in type-III-secretion chaperones and regulators. FEMS Microbiol. Lett. 223:53-60.
38. Mueller CA, Broz P, Cornelis GR. 2008. The type III secretion system tip complex and translocon. Mol. Microbiol. 68:1085-1095.
39. Salomonsson EN, Forslund A-L, Forsberg A. 2011. Type IV pili in Francisella-a virulence trait in an intracellular pathogen. Front. Microbiol. 2:29. doi:10.3389/fmicb.2011.00029.
40. Bröms JE, Forslund A-L, Forsberg A, Francis MS. 2003. PcrH of Pseudomonas aeruginosa is essential for secretion and assembly of the type III translocon. J. Infect. Dis. 188:1909-1921.
41. Mavris M, Page AL, Tournebize R, Demers B, Sansonetti P, Parsot C. 2002. Regulation of transcription by the activity of the Shigella flexneri type III secretion apparatus. Mol. Microbiol. 43:1543-1553.
42. Ménard R, Sansonetti P, Parsot C. 1994. The secretion of the Shigella flexneri Ipa invasins is activated by epithelial cells and controlled by IpaB and IpaD. EMBO J. 13:5293-5302.
43. Watson AA, Alm RA, Mattick JS. 1996. Identification of a gene, pilF, required for type 4 fimbrial biogenesis and twitching motility in Pseudomonas aeruginosa. Gene 180:49-56.
44. Kondo Y, Ohara N, Sato K, Yoshimura M, Yukitake H, Naito M, Fujiwara T, Nakayama K. 2010. Tetratricopeptide repeat proteinassociated proteins contribute to the virulence of Porphyromonas gingivalis. Infect. Immun. 78:2846-2856.
45. Walburger A, Koul A, Ferrari G, Nguyen L, Prescianotto-Baschong C, Huygen K, Klebl B, Thompson C, Bacher G, Pieters J. 2004. Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science 304:1800-1804.
46. Asare R, Abu Kwaik Y. 2010. Molecular complexity orchestrates modulation of phagosome biogenesis and escape to the cytosol of macrophages by Francisella tularensis. Environ. Microbiol. 12:2559-2586.
47. Qin A, Mann BJ. 2006. Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2. BMC Microbiol. 6:69. doi:10.1186/1471-2180-6-69.
48. Dieppedale J, Sobral D, Dupuis M, Dubail I, Klimentova J, Stulik J, Postic G, Frapy E, Meibom KL, Barel M, Charbit A. 2011. Identification of a putative chaperone involved in stress resistance and virulence in Francisella tularensis. Infect. Immun. 79:1428-1439.
49. Cornelis GR, Wolf-Watz H. 1997. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol. Microbiol. 23:861-867.
50. Navarro L, Alto NM, Dixon JE. 2005. Functions of the Yersinia effector proteins in inhibiting host immune responses. Curr. Opin. Microbiol. 8:21-27.
51. Francis MS, Lloyd SA, Wolf-Watz H. 2001. The type III secretion chaperone LcrH co-operates with YopD to establish a negative, regulatory loop for control of Yop synthesis in Yersinia pseudotuberculosis. Mol. Microbiol. 42:1075-1093.
52. Bröms JE, Edqvist PJ, Carlsson KE, Forsberg A, Francis MS. 2005. Mapping of a YscY binding domain within the LcrH chaperone that is required for regulation of Yersinia type III secretion. J. Bacteriol. 187: 7738-7752.
53. Finck-Barbançon V, Goranson J, Zhu L, Sawa T, Wiener-Kronish JP, Fleiszig SM, Wu C, Mende-Mueller L, Frank DW. 1997. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 25:547-557.
54. Frithz-Lindsten E, Du Y, Rosqvist R, Forsberg A. 1997. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type IIIdependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments. Mol. Microbiol. 25:1125-1139.
55. Yahr TL, Goranson J, Frank DW. 1996. Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway. Mol. Microbiol. 22:991-1003.
56. Yahr TL, Vallis AJ, Hancock MK, Barbieri JT, Frank DW. 1998. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc. Natl. Acad. Sci. U. S. A. 95:13899-13904.
57. Kaufman MR, Jia J, Zeng L, Ha U, Chow M, Jin S. 2000. Pseudomonas aeruginosa mediated apoptosis requires the ADP-ribosylating activity of ExoS. Microbiology 146(Pt 10):2531-2541.
58. Sundin C, Wolfgang MC, Lory S, Forsberg A, Frithz-Lindsten E. 2002. Type IV pili are not specifically required for contact dependent translocation of exoenzymes by Pseudomonas aeruginosa. Microb. Pathog. 33:265-277.
59. Allmond LR, Karaca TJ, Nguyen VN, Nguyen T, Wiener-Kronish JP, Sawa T. 2003. Protein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion system. Infect. Immun. 71:2230-2233.
60. Schroeder GN, Hilbi H. 2008. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin. Microbiol. Rev. 21:134-156.
61. Maurelli AT, Baudry B, d'Hauteville H, Hale TL, Sansonetti PJ. 1985. Cloning of plasmid DNA sequences involved in invasion of HeLa cells by Shigella flexneri. Infect. Immun. 49:164-171.
62. Ménard R, Prevost MC, Gounon P, Sansonetti P, Dehio C. 1996. The secreted Ipa complex of Shigella flexneri promotes entry into mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 93:1254-1258.
63. Ménard R, Sansonetti PJ, Parsot C. 1993. Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J. Bacteriol. 175:5899-5906.
64. Parsot C, Ageron E, Penno C, Mavris M, Jamoussi K, d'Hauteville H, Sansonetti P, Demers B. 2005. A secreted anti-activator, OspD1, and its chaperone, Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri. Mol. Microbiol. 56: 1627-1635.
65. Zychlinsky A, Kenny B, Ménard R, Prevost MC, Holland IB, Sansonetti PJ. 1994. IpaB mediates macrophage apoptosis induced by Shigella flexneri. Mol. Microbiol. 11:619-627.
66. Birket SE, Harrington AT, Espina M, Smith ND, Terry CM, Darboe N, Markham AP, Middaugh CR, Picking WL, Picking WD. 2007. Preparation and characterization of translocator/chaperone complexes and their component proteins from Shigella flexneri. Biochemistry 46:8128-8137.
67. Kane CD, Schuch R, Day WA, Jr, Maurelli AT. 2002. MxiE regulates intracellular expression of factors secreted by the Shigella flexneri 2a type III secretion system. J. Bacteriol. 184:4409-4419.
68. Barta ML, Zhang L, Picking WL, Geisbrecht BV. 2010. Evidence for alternative quaternary structure in a bacterial type III secretion system chaperone. BMC Struct. Biol. 10:21. doi:10.1186/1472-6807-10-21.
69. Koo J, Tammam S, Ku SY, Sampaleanu LM, Burrows LL, Howell PL. 2008. PilF is an outer membrane lipoprotein required for multimerization and localization of the Pseudomonas aeruginosa type IV pilus secretin. J. Bacteriol. 190:6961-6969.
70. Scherr N, Honnappa S, Kunz G, Mueller P, Jayachandran R, Winkler F, Pieters J, Steinmetz MO. 2007. Structural basis for the specific inhibition of protein kinase G, a virulence factor of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 104:12151-12156.
71. Tiwari D, Singh RK, Goswami K, Verma SK, Prakash B, Nandicoori VK. 2009. Key residues in Mycobacterium tuberculosis protein kinase G play a role in regulating kinase activity and survival in the host. J. Biol. Chem. 284:27467-27479.
72. Cowley S, Ko M, Pick N, Chow R, Downing KJ, Gordhan BG, Betts JC, Mizrahi V, Smith DA, Stokes RW, Av-Gay Y. 2004. The Mycobacterium tuberculosis protein serine/threonine kinase PknG is linked to cellular glutamate/glutamine levels and is important for growth in vivo. Mol. Microbiol. 52:1691-1702.
73. Cortajarena AL, Yi F, Regan L. 2008. Designed TPR modules as novel anticancer agents. ACS Chem. Biol. 3:161-166.
74. Horibe T, Kohno M, Haramoto M, Ohara K, Kawakami K. 2011. Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent. J. Transl. Med. 9:8. doi:10.1186/1479-5876-9-8.
75. Oyston PC, Quarry JE. 2005. Tularemia vaccine: past, present and future. Antonie Van Leeuwenhoek 87:277-281.